The Flowr Corporation (TSXV:FLWR) cultivates, produces and sells premium cannabis products primarily in Canada with historical operations in Portugal; the company offers dried flowers, pre-rolls, oils and other formats including vaporization, ingestion and topical products for medical and recreational markets. Founded in 2016 and headquartered in Toronto, Ontario, Flowr operates through its Canadian segment focused on licensed production at facilities such as the Kelowna campus in British Columbia, targeting high-yield premium flower and adjacent derivatives; it previously managed the Holigen segment in Portugal encompassing an EU GMP-certified indoor facility in Sintra and an outdoor site in Aljustrel before completing a $35 million divestiture of Holigen Holdings to Akanda Corp. in 2022. Geographically, Flowr serves the Canadian adult-use and medical cannabis sectors nationwide alongside past international medical exports from Europe, emphasizing high-THC strains like BC Pink Kush and BC Black Cherry. Recent major changes include the 2022 sale of its Okanagan operations and research facility to Avant Brands, a shift that streamlined its balance sheet amid creditor proceedings; the company also divested the Kelowna Research Station R&D site to Hawthorne Canada and continues to prioritize domestic premium production following earlier international expansions and funding rounds such as a C$15.9 million bought deal in 2021.